MRKH syndrome is a congenital condition in which the uterus and vagina are underdeveloped or absent, even though the ovaries and external genitalia develop normally. It affects roughly 1 in 5,000 females at birth. The full name, Mayer-Rokitansky-Küster-Hauser syndrome, comes from the four physicians who first described it. Most people learn they have it during their teenage years when their period never arrives.
What Happens in the Body
During the fifth and sixth weeks of pregnancy, structures called Müllerian ducts normally begin forming what will become the uterus, fallopian tubes, and upper vagina. In MRKH, these ducts fail to develop properly or don’t fuse together as expected. The result is a range of outcomes: some people are born without a uterus entirely, others have small remnant tissue where the uterus would be, and the vaginal canal may be shortened or completely absent.
Because the ovaries develop from a separate set of tissues, they typically function normally. That means hormone levels, breast development, body hair, and other puberty milestones happen on schedule. Chromosomes are also typical (46,XX). The one thing that doesn’t happen is menstruation, since there is no uterine lining to shed.
Type I vs. Type II
MRKH is split into two types based on whether the reproductive differences occur alone or alongside other physical variations.
- Type I (isolated): The uterus and upper vagina are absent or underdeveloped, but the rest of the body is unaffected. The fallopian tubes are typically normal.
- Type II (MURCS association): The reproductive differences are accompanied by abnormalities in other organ systems. The acronym MURCS stands for Müllerian duct aplasia, renal dysplasia, and cervical somite anomalies. Common findings include a missing or misplaced kidney, fused cervical vertebrae, scoliosis, and hearing problems caused by abnormal middle-ear bones. Heart defects and differences in the fingers or toes occur less frequently.
Up to 53% of people with MRKH have at least one additional congenital difference outside the reproductive system, which is why screening the kidneys, spine, and other structures is a standard part of the workup.
How MRKH Is Diagnosed
The most common path to diagnosis starts when a teenager reaches 15 or 16 without getting a period, a situation called primary amenorrhea. Because puberty otherwise looks completely normal, the absence of menstruation is often the only clue. A physical exam may reveal a shortened or absent vaginal canal.
Ultrasound is usually the first imaging test, but it can be difficult to interpret, especially before puberty. MRI is considered the gold standard because it provides detailed views of soft tissue without radiation. On MRI, radiologists look for the absence or underdevelopment of the uterus, assess vaginal length, confirm that the ovaries appear normal with healthy follicles, and check for kidney or spinal abnormalities. Rudimentary uterine structures show up on MRI in about 90% of cases. Laparoscopy is not needed to confirm the diagnosis but may be used later if pelvic pain becomes an issue.
Genetic Factors
The exact cause of MRKH remains unclear, but it is not random in every case. Researchers have identified several chromosomal regions and genes that appear to play a role. Genes involved in early embryonic development of the reproductive and urinary systems are the strongest candidates. These include genes that influence how the mesoderm (the tissue layer that gives rise to reproductive organs) differentiates, as well as genes that direct the patterning of the reproductive tract during the earliest weeks of pregnancy.
Some of these genetic variants have been linked specifically to Type II MRKH and kidney abnormalities, while others are associated with ovarian development. When MRKH appears alongside signs of excess androgen (like unusual hair growth patterns), a different set of genetic pathways may be involved. In most cases, though, the condition appears sporadically with no clear family pattern, and many people with MRKH have no identifiable genetic mutation at all.
Creating a Functional Vagina
The first-line treatment is nonsurgical vaginal dilation. This involves using graduated dilators to gradually stretch and lengthen vaginal tissue over weeks to months. When someone is emotionally prepared and consistent with the process, success rates range from 90% to 96%. One method involves simply applying pressure with handheld dilators for short periods each day. Another uses a small seat-mounted device that lets body weight do some of the work. In clinical reports, some patients achieved a functional vaginal length of 7 to 8 centimeters within 8 weeks to 4 months.
The advantages of dilation over surgery are significant: no surgical scarring, lower risk of complications, and tissue that behaves more like natural vaginal lining. It does require patience and motivation, which is why timing matters. Clinicians generally recommend starting when the person feels ready and understands the process, not simply when the diagnosis is made.
When dilation is not successful or not preferred, surgical options exist. The two most studied laparoscopic procedures produce comparable results: both achieve an average vaginal length of about 8 to 9 centimeters at one year, and sexual function scores in both groups fall within the normal range. One technique takes roughly 40 minutes of operating time while the other averages about two hours, but functional outcomes are similar. Because these surgeries are uncommon, finding a surgeon with specific experience matters. The first procedure tends to have better outcomes than any revision surgery.
Fertility and Having Children
Because the ovaries work normally in MRKH, eggs can be retrieved for in vitro fertilization. The embryo is then carried by a gestational surrogate. This is currently the most established path to having a biological child.
Uterine transplantation is a newer option that has allowed some people with MRKH to carry and deliver a pregnancy themselves. It involves receiving a donor uterus, becoming pregnant through IVF, delivering by cesarean section, and then having the transplanted uterus removed. The procedure remains rare and is available only at specialized centers, but it represents a meaningful shift in what is possible.
Emotional and Psychological Impact
Being told as a teenager that you were born without a uterus and may not menstruate or carry a pregnancy is a significant emotional event. Research consistently shows that people with MRKH experience higher rates of anxiety and depression compared to peers without the condition. Studies have also documented lower self-esteem, social insecurity, and sexuality-related distress, including concerns about body image and intimacy. Some individuals report suicidal thoughts. Mental health quality of life tends to be more affected than physical quality of life.
Even after treatment to create a functional vagina, some of these feelings persist. People with MRKH report higher rates of sexual dysfunction and lower sexual confidence than control groups, suggesting that the psychological dimensions of the condition extend well beyond the physical ones. Cognitive behavioral therapy delivered in a group setting has been shown to significantly reduce psychological symptoms. Connecting with peer support groups, where people share experiences with others who truly understand the diagnosis, is one of the most consistently recommended interventions. Organizations like the MRKH Foundation and Beautiful You MRKH Foundation provide community and resources specifically for people navigating this condition.